Back to Authors

Chakhava, George

Mayo Clinic

Multiprofile Clinic Consilium Medulla, Georgian Association of Medical Specialties Tbilisi Georgia

Citations 1

Primary Results of PROMISE-1 (Prevention Of Migraine via Intravenous eptinezumab Safety and Efficacy–1) Trial: a Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for Prevention of Frequent Episo
Saper, Joel R., Kudrow, David, Hirman, Joe, Silberstein, Stephen D., Chakhava, George, Smith, Jeff , Lipton, Richard B. , Dodick, David W.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s20.001 Get It